Identification of Combinations of Approved Drugs With Synergistic Activity Against Ebola Virus in Cell Cultures.

Autor: Dyall J; Integrated Research Facility, Division of Clinical Research, Frederick., Nelson EA; Department of Cell Biology, University of Virginia, Charlottesville., DeWald LE; Integrated Research Facility, Division of Clinical Research, Frederick., Guha R; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland., Hart BJ; Integrated Research Facility, Division of Clinical Research, Frederick., Zhou H; Integrated Research Facility, Division of Clinical Research, Frederick., Postnikova E; Integrated Research Facility, Division of Clinical Research, Frederick., Logue J; Integrated Research Facility, Division of Clinical Research, Frederick., Vargas WM; Integrated Research Facility, Division of Clinical Research, Frederick., Gross R; Integrated Research Facility, Division of Clinical Research, Frederick., Michelotti J; Integrated Research Facility, Division of Clinical Research, Frederick., Deiuliis N; Integrated Research Facility, Division of Clinical Research, Frederick., Bennett RS; Integrated Research Facility, Division of Clinical Research, Frederick., Crozier I; Integrated Research Facility, Division of Clinical Research, Frederick., Holbrook MR; Integrated Research Facility, Division of Clinical Research, Frederick., Morris PJ; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland., Klumpp-Thomas C; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland., McKnight C; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland., Mierzwa T; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland., Shinn P; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland., Glass PJ; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick., Johansen LM; Zalicus, Cambridge, Massachusetts., Jahrling PB; Integrated Research Facility, Division of Clinical Research, Frederick.; Emerging Viral Pathogens Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick., Hensley LE; Integrated Research Facility, Division of Clinical Research, Frederick., Olinger GG Jr; Integrated Research Facility, Division of Clinical Research, Frederick., Thomas C; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland., White JM; Department of Cell Biology, University of Virginia, Charlottesville.

Publikováno v: The Journal of infectious diseases [J Infect Dis] 2018 Nov 22; Vol. 218 (suppl_5), pp. S672-S678.

Epigenetic regulation of microglia and neurons by proinflammatory signaling following adolescent intermittent ethanol (AIE) exposure and in human AUD.

Autor: Crews, Fulton T.¹ fulton_crews@med.unc.edu, Macht, Victoria¹, Vetreno, Ryan P.¹

Publikováno v: Advances in Drug & Alcohol Research. 2024, p1-16. 16p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.